Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX
Ortho Clinical Diagnostics Holdings PLC
Operating Income
Ortho Clinical Diagnostics Holdings PLC
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Ortho Clinical Diagnostics Holdings PLC
NASDAQ:OCDX
|
Operating Income
$180.9m
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.4B
|
CAGR 3-Years
39%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
See Also
What is Ortho Clinical Diagnostics Holdings PLC's Operating Income?
Operating Income
180.9m
USD
Based on the financial report for Jan 2, 2022, Ortho Clinical Diagnostics Holdings PLC's Operating Income amounts to 180.9m USD.
What is Ortho Clinical Diagnostics Holdings PLC's Operating Income growth rate?
Operating Income CAGR 3Y
14%
Over the last year, the Operating Income growth was 105%. The average annual Operating Income growth rates for Ortho Clinical Diagnostics Holdings PLC have been 14% over the past three years .